Aurora Therapeutics
Founded 2026 · $16.0M raised
- Employees
- 1–10
- Founded
- 2026
- Business Model
- B2B
- Website
- auroratherapeutics.com
- Total Funding
- $16.0M
- Last Round
- $16.0M SeedJan 2026
- Rounds
- 1
About
Aurora Therapeutics develops personalized CRISPR gene-editing medicines for patients with rare diseases.
Summary
Aurora Therapeutics is a Biotech company, founded in 2026. It has raised $16.0M in total across 1 round, most recently a $16.0M Seed round in Jan 2026. Investors include Menlo Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...